Related Experiment Video
Updated: Mar 13, 2026

08:52
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
3.6K
Histopathological subgroups in knee osteoarthritis.
L A Wyatt1, B J Moreton2, P I Mapp1
1Arthritis Research UK Pain Centre, University of Nottingham, Nottingham, NG5 1PB, UK; Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Nottingham, UK.
Osteoarthritis and Cartilage
|November 8, 2016
Summary
Osteoarthritis (OA) is a complex disease. This study identified three distinct OA subgroups based on histopathology, revealing that synovitis severity is key to defining these stages and improving targeted therapies.
Area of Science:
- Orthopedics
- Rheumatology
- Pathology
Background:
- Osteoarthritis (OA) is a complex, multi-tissue disease with varied progression.
- Understanding the histopathological features of OA is crucial for developing effective treatments.
Purpose of the Study:
- To investigate if distinct histopathological features define different stages of knee OA progression.
- To identify discrete OA subgroups based on validated histopathological measures.
Main Methods:
- Analysis of medial tibial plateaux and synovium from post-mortem and arthroplasty donations.
- Rasch analysis of Mankin scores, supplemented with subchondral bone and synovitis scores.
- Latent class analysis (LCA) to identify histopathological subgroups.
Main Results:
- Chondropathy, synovitis, and osteochondral pathology were associated with OA but also present in controls.
- Tidemark breaching was significantly greater in the OA group compared to controls.
- Three histopathological subgroups were identified: mild OA, and severe OA with either mild or moderate/severe synovitis.
Conclusions:
- Synovitis presence and severity are critical for defining distinct OA histopathological subgroups.
- A pathological continuum exists between normal and OA states, with no discrete 'normal' subgroup.
- Identifying OA subgroups and their clinical correlates can accelerate therapeutic development.

